-
1
Impact of the angiotensin receptor‐neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls
Published 2023-09-01Subjects: “…Angiotensin receptor‐neprilysin inhibitor…”
Get full text
Article -
2
Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
Published 2020-07-01Subjects: “…angiotensin receptor–neprilysin inhibitor…”
Get full text
Article -
3
Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor
Published 2023-08-01Subjects: Get full text
Article -
4
Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary
Published 2021-03-01Subjects: Get full text
Article -
5
Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study
Published 2025-02-01Subjects: “…angiotensin receptor-neprilysin inhibitor…”
Get full text
Article -
6
Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
Published 2021-03-01Subjects: “…angiotensin receptor neprilysin inhibitor…”
Get full text
Article -
7
Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial
Published 2018-06-01Subjects: “…angiotensin receptor neprilysin inhibitor…”
Get full text
Article -
8
Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime
Published 2022-10-01Subjects: Get full text
Article -
9
Effects of angiotensin receptor-neprilysin inhibitor on ketone body metabolism in pre-heart failure/heart failure patients
Published 2024-07-01Subjects: “…Angiotensin receptor-neprilysin inhibitor (ARNI)…”
Get full text
Article -
10
Sacubitril/valsartan: from the PARADIGM-HF trial results to heart failure patients in internal medicine. A narrative review
Published 2021-03-01Subjects: Get full text
Article -
11
Sacubitril with valsartan, a modern pharmacotherapy in heart failure - a literature review
Published 2024-07-01Subjects: “…angiotensin receptor-neprilysin inhibitor…”
Get full text
Article -
12
Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series
Published 2020-12-01Subjects: Get full text
Article -
13
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
Published 2020-01-01Subjects: “…angiotensin receptor/neprilysin inhibitor…”
Get full text
Article -
14
Getting the “Right” Perspective on Angiotensin Receptor–Neprilysin Inhibition in Heart Failure
Published 2020-07-01Subjects: Get full text
Article -
15
Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
Published 2021-09-01Subjects: “…angiotensin receptor-neprilysin inhibitor…”
Get full text
Article -
16
Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
Published 2023-12-01Subjects: Get full text
Article -
17
Initiation, treatment response evaluation, and safety monitoring of angiotensin receptor/neprilysin inhibitors (Sacubitril/Valsartan) in the management of heart failure in India: A...
Published 2023-01-01Subjects: “…angiotensin receptor/neprilysin inhibitor…”
Get full text
Article -
18
Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP‐HF
Published 2022-06-01Subjects: “…angiotensin receptor neprilysin inhibitor…”
Get full text
Article -
19
Application of Angiotensin Receptor–Neprilysin Inhibitor in Chronic Kidney Disease Patients: Chinese Expert Consensus
Published 2022-07-01Subjects: Get full text
Article -
20
Sacubitril/Valsartan Shows Improvement of the Cardio-Ankle Vascular Index in a Hypertensive Patient
Published 2023-08-01Subjects: Get full text
Article